Clinical outcomes of AngioJet rheolytic thrombectomy in the treatment of May–Thurner syndrome-related deep venous thrombosis
Objective May–Thurner syndrome (MTS) is an anatomic stenotic variation associated with deep vein thrombosis (DVT) of the left leg. The classical DVT treatment strategy is medical treatment without thrombus removal. This study was performed to assess the clinical outcomes of the combination of AngioJ...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-06-01
|
| Series: | Journal of International Medical Research |
| Online Access: | https://doi.org/10.1177/03000605221100134 |
| _version_ | 1818533726738448384 |
|---|---|
| author | Wen-Cheng Wei Chun-Hsien Hsin Hsuan-Tzu Yang Ta-Wei Su I-Hao Su Sung-Yu Chu Po-Jen Ko Sheng-Yueh Yu Chun-Hui Lee |
| author_facet | Wen-Cheng Wei Chun-Hsien Hsin Hsuan-Tzu Yang Ta-Wei Su I-Hao Su Sung-Yu Chu Po-Jen Ko Sheng-Yueh Yu Chun-Hui Lee |
| author_sort | Wen-Cheng Wei |
| collection | DOAJ |
| description | Objective May–Thurner syndrome (MTS) is an anatomic stenotic variation associated with deep vein thrombosis (DVT) of the left leg. The classical DVT treatment strategy is medical treatment without thrombus removal. This study was performed to assess the clinical outcomes of the combination of AngioJet™ rheolytic thrombectomy and stenting for treatment of MTS-related DVT. Methods We conducted a retrospective cohort study of patients treated for MTS-related DVT from January 2017 to June 2020 at a single institution. Results Fourteen patients (nine women) underwent AngioJet™ rheolytic thrombectomy for MTS-related DVT during the study period. The median DVT onset time was 8 days (interquartile range (IQR), 3–21 days). The median procedure time was 130 minutes (IQR, 91–189 minutes), and the median hospital stay was 7 days (IQR, 5–26 days). One patient had a residual thrombus and occluded iliac stent and underwent adjuvant catheter-directed thrombolysis for revascularization. The primary patency rate for the iliac stent was 92.9% at 12 months. Conclusion Concomitant AngioJet™ rheolytic thrombectomy and stenting of MTS-induced lesions may be beneficial for patients with MTS-related DVT. |
| first_indexed | 2024-12-11T18:02:32Z |
| format | Article |
| id | doaj.art-f3d99f7be13c446da81b306a70264b97 |
| institution | Directory Open Access Journal |
| issn | 1473-2300 |
| language | English |
| last_indexed | 2024-12-11T18:02:32Z |
| publishDate | 2022-06-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Journal of International Medical Research |
| spelling | doaj.art-f3d99f7be13c446da81b306a70264b972022-12-22T00:55:51ZengSAGE PublishingJournal of International Medical Research1473-23002022-06-015010.1177/03000605221100134Clinical outcomes of AngioJet rheolytic thrombectomy in the treatment of May–Thurner syndrome-related deep venous thrombosisWen-Cheng WeiChun-Hsien HsinHsuan-Tzu YangTa-Wei SuI-Hao SuSung-Yu ChuPo-Jen KoSheng-Yueh YuChun-Hui LeeObjective May–Thurner syndrome (MTS) is an anatomic stenotic variation associated with deep vein thrombosis (DVT) of the left leg. The classical DVT treatment strategy is medical treatment without thrombus removal. This study was performed to assess the clinical outcomes of the combination of AngioJet™ rheolytic thrombectomy and stenting for treatment of MTS-related DVT. Methods We conducted a retrospective cohort study of patients treated for MTS-related DVT from January 2017 to June 2020 at a single institution. Results Fourteen patients (nine women) underwent AngioJet™ rheolytic thrombectomy for MTS-related DVT during the study period. The median DVT onset time was 8 days (interquartile range (IQR), 3–21 days). The median procedure time was 130 minutes (IQR, 91–189 minutes), and the median hospital stay was 7 days (IQR, 5–26 days). One patient had a residual thrombus and occluded iliac stent and underwent adjuvant catheter-directed thrombolysis for revascularization. The primary patency rate for the iliac stent was 92.9% at 12 months. Conclusion Concomitant AngioJet™ rheolytic thrombectomy and stenting of MTS-induced lesions may be beneficial for patients with MTS-related DVT.https://doi.org/10.1177/03000605221100134 |
| spellingShingle | Wen-Cheng Wei Chun-Hsien Hsin Hsuan-Tzu Yang Ta-Wei Su I-Hao Su Sung-Yu Chu Po-Jen Ko Sheng-Yueh Yu Chun-Hui Lee Clinical outcomes of AngioJet rheolytic thrombectomy in the treatment of May–Thurner syndrome-related deep venous thrombosis Journal of International Medical Research |
| title | Clinical outcomes of AngioJet rheolytic thrombectomy in the treatment of May–Thurner syndrome-related deep venous thrombosis |
| title_full | Clinical outcomes of AngioJet rheolytic thrombectomy in the treatment of May–Thurner syndrome-related deep venous thrombosis |
| title_fullStr | Clinical outcomes of AngioJet rheolytic thrombectomy in the treatment of May–Thurner syndrome-related deep venous thrombosis |
| title_full_unstemmed | Clinical outcomes of AngioJet rheolytic thrombectomy in the treatment of May–Thurner syndrome-related deep venous thrombosis |
| title_short | Clinical outcomes of AngioJet rheolytic thrombectomy in the treatment of May–Thurner syndrome-related deep venous thrombosis |
| title_sort | clinical outcomes of angiojet rheolytic thrombectomy in the treatment of may thurner syndrome related deep venous thrombosis |
| url | https://doi.org/10.1177/03000605221100134 |
| work_keys_str_mv | AT wenchengwei clinicaloutcomesofangiojetrheolyticthrombectomyinthetreatmentofmaythurnersyndromerelateddeepvenousthrombosis AT chunhsienhsin clinicaloutcomesofangiojetrheolyticthrombectomyinthetreatmentofmaythurnersyndromerelateddeepvenousthrombosis AT hsuantzuyang clinicaloutcomesofangiojetrheolyticthrombectomyinthetreatmentofmaythurnersyndromerelateddeepvenousthrombosis AT taweisu clinicaloutcomesofangiojetrheolyticthrombectomyinthetreatmentofmaythurnersyndromerelateddeepvenousthrombosis AT ihaosu clinicaloutcomesofangiojetrheolyticthrombectomyinthetreatmentofmaythurnersyndromerelateddeepvenousthrombosis AT sungyuchu clinicaloutcomesofangiojetrheolyticthrombectomyinthetreatmentofmaythurnersyndromerelateddeepvenousthrombosis AT pojenko clinicaloutcomesofangiojetrheolyticthrombectomyinthetreatmentofmaythurnersyndromerelateddeepvenousthrombosis AT shengyuehyu clinicaloutcomesofangiojetrheolyticthrombectomyinthetreatmentofmaythurnersyndromerelateddeepvenousthrombosis AT chunhuilee clinicaloutcomesofangiojetrheolyticthrombectomyinthetreatmentofmaythurnersyndromerelateddeepvenousthrombosis |